|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/32 | |
| A61K 9/36 | |||
| A61K 9/16 | |||
| A61K 9/24 | |||
| A61K 9/26 |
| (11) | Patento numeris | 2063872 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07801970.0 |
| Europos patento paraiškos padavimo data | 2007-08-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-06-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-05-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2007/007549 |
| Data | 2007-08-29 |
| (87) | Numeris | WO 2008/025535 |
| Data | 2008-03-06 |
| (30) | Numeris | Data | Šalis |
| 824043 P | 2006-08-30 | US | |
| 824054 P | 2006-08-30 | US |
| (72) |
VERGNAULT, Guy, FR
GRENIER, Pascal, FR
NHAMIAS, Alain, FR
|
| (73) |
Jagotec AG,
Eptingerstrasse 51, 4132 Muttenz,
CH
|
| (54) | CONTROLLED RELEASE ORAL DOSAGE FORMULATIONS COMPRISING A CORE AND ONE OR MORE BARRIER LAYERS |
| CONTROLLED RELEASE ORAL DOSAGE FORMULATIONS COMPRISING A CORE AND ONE OR MORE BARRIER LAYERS |